PMV Pharmaceuticals, Inc (PMVP) insider trading
Every open-market stock purchase and sale by PMV Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $1.5M over the last 12 months (1 sale). No open-market buys.
- Last insider buy: Ra Capital Management L.p. (10% owner), $17.1M, 6 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $1.5M (1 sale). Last close $1.09 on Jun 7, 2026.
Recent PMVP insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 4, 2026 | Laurie Stelzer (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Kirsten Flowers (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Carol Giltner Gallagher (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Carol Giltner Gallagher (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Arnold J Levine (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Charles M Baum (Insider) | Bought (not open market) | — |
| Mar 5, 2026 | Robert Ticktin (COO) | Bought (not open market) | — |
| Mar 5, 2026 | Deepika Jalota (C-suite exec) | Bought (not open market) | — |
| Mar 5, 2026 | David Henry Mack (CEO) | Bought (not open market) | — |
| Mar 5, 2026 | Michael Carulli (CFO) | Bought (not open market) | — |
| Oct 27, 2025 | David Henry Mack (CEO) | Bought (not open market) | — |
| Oct 23, 2025 | Orbimed Advisors LLC (10% owner) | Sold | $1.5M |
Who's trading PMVP
- Kirsten Flowers, Insider: other filings, last Jun 4, 2026
- Arnold J Levine, Insider: other filings, last Jun 4, 2026
- Carol Giltner Gallagher, Insider: other filings, last Jun 4, 2026
- Laurie Stelzer, Insider: other filings, last Jun 4, 2026
- Charles M Baum, Insider: other filings, last Jun 4, 2026
- Robert Ticktin, COO: other filings, last Mar 5, 2026
- Michael Carulli, CFO: other filings, last Mar 5, 2026
- Deepika Jalota, C-suite exec: other filings, last Mar 5, 2026
- David Henry Mack, CEO: other filings, last Mar 5, 2026
- Orbimed Advisors LLC, 10% owner: sold $1.5M (1 sale), last Oct 23, 2025
Get free alerts when an insider at PMV Pharmaceuticals, Inc files a new trade →